Using chromatin immunoprecipitation (ChIP) assay, Johnston and colleagues demonstrated that BRCA1 associates with the rDNA loci in multiple breast cancer cell lines (Johnston et al., 2016). Here, BRCA1 is linked to breast carcinoma.